Opus Genetics, Inc. — SC 13D/A Filings
12 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Opus Genetics, Inc. (IRD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Opus Genetics, Inc. has filed 12 SC 13D/A documents with the SEC since 2003. To view all SEC filings by Opus Genetics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10KSB
10QSB
144
25
3
4
4/A
424A
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PRER14A
PRER14C
PRRN14A
PX14A6G
REGDEX
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | AHN CHANG HO SC 13D A NO 5 10-7-2013 (REXAHN PHARMACEUTICALS, INC) | 0001140361-13-038281 | Oct 9, 2013 | — |
| SC 13D/A | REXAHN PHARMACEUTICALS, INC SC 13DA 7-20-2012 (AHN) | 0001140361-12-033571 | Jul 20, 2012 | — |
| SC 13D/A | REXAHN PHARMACEUTICALS INC SC 13D A 5-31-2011 | 0001140361-11-031325 | Jun 3, 2011 | — |
| SC 13D/A | REXAHN PHARMACEUTICALS SC 13D/A 5-18-2011 | 0001140361-11-029092 | May 20, 2011 | — |
| SC 13D/A | REXAHN PHARMACEUTICAL INC 13D A 9-9-2009 | 0001140361-09-022035 | Sep 30, 2009 | — |
| SC 13D/A | REXAHN PHARMACEUTICALS SC 13D A 5-4-2009 | 0001140361-09-012055 | May 13, 2009 | — |
| SC 13D/A | REXAHN PHARMACEUTICAL INC 13DA 12-24-2007 | 0001140361-07-025106 | Dec 26, 2007 | — |
| SC 13D/A | REXAHN PHARMACEUTICALS INC SC 13DA 12-24-2007 | 0001140361-07-025104 | Dec 26, 2007 | — |
| SC 13D/A | REXHAN PHARMACEUTICALS SC-13D/A 11-20-2007 | 0001140361-07-023162 | Nov 30, 2007 | — |
| SC 13D/A | REXAHN PHARMACEUTICALS SC-13DA 11-19-2007 | 0001140361-07-023112 | Nov 29, 2007 | — |
| SC 13D/A | — | 0000893838-05-000134 | May 23, 2005 | — |
| SC 13D/A | — | 0000893838-05-000133 | May 23, 2005 | — |